Watching the wrong presentation. Talk with Dr. Kapp as I did.
“For wounds to heal and for patients to require fewer subsequent doctor visits, damaged and devitalized tissue must be properly cut away to obtain healthy, pink tissue, which often bleeds. Unfortunately, wounds are often under treated instead of debrided because they are cared for in outpatient settings not conducive to aggressively treating deeper, bleeding wounds. Arch Therapeutics’ AC5 advanced wound dressing technology could be a breakthrough, democratizing the approach to wound care in a wide range of treatment settings with potential utility across all phases of healing, starting with hemostasis.”
Daniel Kapp, MD Surgeon (Specialties: Plastic Surgery and Wound Care) Chief of Plastic Surgery, Palm Beach Gardens Medical Center Medical Director, Wound Healing Center at Jupiter Medical Center
“With increased numbers of patients on anti-coagulants, bleeding from even small procedures is becoming a more important issue each day. The concept of AC5, which selfassembles on tissue, provides a novel technology that can treat multiple areas of the body and can also be used with other biosurgical technologies. It has tremendous potential in bleeding wounds and may also provide unique solutions to leakage of other fluids such as lymphatics.”
Dennis Orgill, MD, PhD Professor of Surgery, Harvard Medical School (Specialties: Plastic and Reconstructive Surgery) Director of the Brigham and Women’s Hospital Wound Care Center, Boston, MA Principal Investigator, Would Healing & Tissue Engineering Laboratory
